CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes
Abstract Generating cardiomyocytes (CMs) from human induced pluripotent stem cells (hiPSCs) has represented a significant advance in our ability to model cardiac disease. Current differentiation protocols, however, have limited use due to their production of heterogenous cell populations, primarily...
Enregistré dans:
Auteurs principaux: | Orlando Chirikian, William R. Goodyer, Elda Dzilic, Vahid Serpooshan, Jan W. Buikema, Wesley McKeithan, HaoDi Wu, Guang Li, Soah Lee, Markus Merk, Francisco Galdos, Aimee Beck, Alexandre J. S. Ribeiro, Sharon Paige, Mark Mercola, Joseph C. Wu, Beth L. Pruitt, Sean M. Wu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d5033e1c1320405bbdfe19a5a5ff8a89 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Microhomology-assisted scarless genome editing in human iPSCs
par: Shin-Il Kim, et autres
Publié: (2018) -
Dissecting transcriptomic signatures of neuronal differentiation and maturation using iPSCs
par: Emily E. Burke, et autres
Publié: (2020) -
NaV1.5 knockout in iPSCs: a novel approach to study NaV1.5 variants in a human cardiomyocyte environment
par: Marion Pierre, et autres
Publié: (2021) -
Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing
par: Erica McGrath, et autres
Publié: (2019) -
Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
par: Tao Ye, et autres
Publié: (2021)